Exact Mass: 663.453235
Exact Mass Matches: 663.453235
Found 360 metabolites which its exact mass value is equals to given mass value 663.453235,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Zucchini factor B
Zucchini factor B is found in fruits. Zucchini factor B is a constituent of seeds of pumpkin (Cucurbita maxima) and squash (Cucurbita pepo) Constituent of seeds of pumpkin (Cucurbita maxima) and squash (Cucurbita pepo). Zucchini factor B is found in fruits and japanese pumpkin.
PE(14:0/16:0)
PE(14:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/16:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/16:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(14:0/16:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(15:0/15:0)
PE(15:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/15:0), in particular, consists of two chains of pentadecanoic acid at the C-1 and C-2 positions. The pentadecanoic acid moieties are derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/15:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PE(15:0/15:0), in particular, consists of two pentadecanoyl chains at positions C-1 and C-2. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(16:0/14:0)
PE(16:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/14:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of myristic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/14:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/14:0), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one tetradecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE-NMe(14:0/15:0)
PE-NMe(14:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/15:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one pentadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PE-NMe(15:0/14:0)
PE-NMe(15:0/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/14:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(14:0/14:0)
PE-NMe2(14:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:0/14:0), in particular, consists of two tetradecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
Phosphatidylethanolamine (15:0/15:0) Abbr: Di-(15)PE
PC(13:0/14:0)[U]
PC(14:0/13:0)[U]
PC(15:0/12:0)[U]
PC(16:0/11:0)[U]
PC(17:0/10:0)
PC(18:0/9:0)[U]
PC(8:0/19:0)
PC(9:0/18:0)
PE(18:0/12:0)[U]
PE(15:0/15:0)
PE(15:0/15:0)[U]
PE(16:0/14:0)
PE(14:0/16:0)
GPEtnNMe2(14:0/14:0)
GPEtnNMe2(14:0/14:0)[U]
PS(12:0/15:1(9Z))
C33H62NO10P (663.4111121999999)
PS(13:0/14:1(9Z))
C33H62NO10P (663.4111121999999)
PS(14:1(9Z)/13:0)
C33H62NO10P (663.4111121999999)
PS(15:1(9Z)/12:0)
C33H62NO10P (663.4111121999999)
Zucchini factor B
PE 30:0
PE-NMe2 28:0
PHODA-PE
C33H62NO10P (663.4111121999999)
Anthenoside A1
Anthenoside A2
[(2R)-2-hexadecanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[5-[[hydroxy(2-quinolin-1-ium-1-ylethoxy)phosphoryl]oxymethyl]oxolan-2-yl]methyl N-octadecylcarbamate
C36H60N2O7P+ (663.4137920000001)
1-octadecanoyl-2-nonanoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 27:0 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and nonanoyl respectively.
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoate
[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-decanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-dodecanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propan-2-yl] hexanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] butanoate
3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]nonadecane-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]nonadec-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]henicos-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]nonadeca-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]henicosa-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]henicosane-1-sulfonic acid
C39H69NO5S (663.4896183999999)
2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytridecane-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentadec-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid
C39H69NO5S (663.4896183999999)
3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentadecane-1-sulfonic acid
C39H69NO5S (663.4896183999999)
2-amino-3-[[2-dodecanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[3-decoxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxypropanoic acid
2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[3-dodecoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid
2-amino-3-[[2-decanoyloxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[2-pentadecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-tetradecoxypropoxy]phosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[3-pentadecoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[2-tetradecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid
2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-[4-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
2-amino-3-[[3-heptanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] henicosanoate
2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[hydroxy-[3-nonanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] octadecanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] heptadecanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate
2-amino-3-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[[3-dodecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[hydroxy-[3-tetradecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[[2-[(Z)-hexadec-9-enoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-amino-3-[[3-decanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(3-Decanoyloxy-2-heptadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Hexadecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Dodecanoyloxy-2-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Tetradecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] heptacosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] hexacosanoate
(4Z,7Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8,12-trien-2-yl]hexadeca-4,7-dienamide
(3-Butanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tetracosanoate
(3-Heptanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Docosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Propanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] pentacosanoate
(10Z,12Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8,12-trien-2-yl]octadeca-10,12-dienamide
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] docosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] tricosanoate
(2-Nonadecanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Henicosanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Acetyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Nonanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
2-amino-3-[hydroxy-[3-propanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2S)-2-amino-3-[hydroxy-[(2R)-2-[(E)-tetradec-9-enoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2S)-2-amino-3-[[(2R)-3-dodecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] heptadecanoate
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] icosanoate
(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2R)-2-amino-3-[[(2S)-3-[(E)-hexadec-9-enoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2R)-2-amino-3-[[(2S)-3-[(E)-hexadec-7-enoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[(2S)-2-decanoyloxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] nonadecanoate
(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2S)-2-amino-3-[hydroxy-[(2R)-3-[(E)-tetradec-9-enoyl]oxy-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate
(2S)-2-amino-3-[[(2R)-2-dodecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
[(2R)-3-decanoyloxy-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S)-3-hexadecanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] octadecanoate
(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C33H62NO10P (663.4111121999999)
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine
Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester (9CI)
Hexadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester (9CI)
1-(1Z-hexadecenyl)-2-dodecanoyl-glycero-3-phosphoserine
phosphatidylethanolamine 30:0
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 0 double bonds.
PC(29:7)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(28:7)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(26:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
n-[(2r,3r,4r,5s,6r)-2-{[(1r,3s,3as,3br,5ar,7s,9as,9bs,11ar)-1-[(2r,6r)-7-(acetyloxy)-6-methylheptan-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
3-o-p-aminobenzoyl-29-o-benzoylmultiflora-7,9(11)-diene-3α,29-diol
{"Ingredient_id": "HBIN009371","Ingredient_name": "3-o-p-aminobenzoyl-29-o-benzoylmultiflora-7,9(11)-diene-3\u03b1,29-diol","Alias": "NA","Ingredient_formula": "C44H57NO4","Ingredient_Smile": "CC1(C(CCC2(C1CC=C3C2=CCC4(C3(CCC5(C4CC(CC5)(C)COC(=O)C6=CC=CC=C6)C)C)C)C)OC(=O)C7=CC=C(C=C7)N)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1043","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}